Nippon Shinyaku (10% owner) buys 2,798,507 shares of CAPR at $5.36 for $15.0M; position grows to 7,090,351 shares (+65.2%)
Nippon Shinyaku, already a 10% shareholder, committed $14,999,997.52 to increase its stake in Capricor Therapeutics by 65.2%, acquiring 2,798,507 shares at $5.36. The stock has since appreciated to $9.10, up 99.6% over 30 days and 96.5% over 90 days, suggesting the transaction occurred near a recent floor—a critical timing inflection. Set against Capricor's fundamentals (unprofitable with -$11.0M net income, quarterly revenue of $4.0M, but explosive annual growth of +886.8%), this represents a major capital commitment by an existing anchor investor rather than a new entrant. The purchase size and subsequent price trajectory merit investor scrutiny into what triggered this significant further concentration of ownership and whether it signals conviction in a turnaround or precedes material strategic announcements.